What is Retatrutide?
Retatrutide is an advanced therapeutic agent designed to address a range of medical conditions through its unique mechanism of action. As a cutting-edge treatment, retatrutide is gaining attention within the medical community for its potential to offer significant health benefits.
Mechanism of Action
Retatrutide operates through a highly specialized mechanism that targets specific cellular pathways. By modulating these pathways, retatrutide can effectively alter disease progression, providing therapeutic benefits that were previously unattainable with conventional treatments. This precision-targeted approach ensures that retatrutide not only addresses the symptoms but also the underlying causes of various health conditions.
Clinical Applications
The versatility of retatrutide allows it to be used in treating a broad spectrum of diseases. Current clinical trials have demonstrated its efficacy in conditions such as obesity, metabolic disorders, inflammatory diseases, and certain types of cancer. The promising results from these trials have paved the way for retatrutide to be considered a potential game-changer in modern medicine.
Benefits and Potential Impact
One of the most significant benefits of retatrutide is its ability to provide targeted treatment with minimal side effects. This is particularly beneficial for patients who have had limited success with existing therapies. Moreover, the potential impact of retatrutide extends beyond individual patient outcomes, as its widespread adoption could lead to shifts in treatment paradigms and healthcare delivery models.
Certificate of Analysis
Property | Description |
Chemical Sequence | Tyr-{Aib}-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-{α-Me-Leu}-Leu-Asp-Lys-{diacid-C20-gamma-Glu-(AEEA)-Lys}-Ala-Gln-{Aib}-Ala-Phe-Ile-Glu-Tyr-Leu-Leu-Glu-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2 (Sodium salt) |
CAS | 2381089-83-2 |
Molecular Formula | C223H343F3N46O70 |
Molecular Weight | 4845.444 g/mol |
CID | N/A |
Appearance | White Lyophilized Powder |
Learn More About Retatrutide
- “Retatrutide, an Agonist of GIP, GLP-1, and Glucagon Receptors, Improves Markers of Pancreatic Beta-Cell Function and Insulin Sensitivity”
- “Effect of Retatrutide on Kidney Parameters in People with Type 2 Diabetes and/or Obesity—A Post-Hoc Analysis of Two Phase 2 Trials”
- “Retatrutide Showcases Historic Weight-Lowering, Glycemic Control Benefits in Phase 2 Data”
- “Triple-Hormone Combination Retatrutide Induces 24% Body Weight Loss”
- “What is Retatrutide Peptide and How Does it Work?”